This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hye Won Park Articles by Mauer, M. Search for Related Content PubMed PubMed Citation Articles by Hye Won Park, Articles by Mauer, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Kidney Diseases Hazardous Substances DB LOSARTAN POTASSIUM Social Bookmarking                         What's this?

Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats

Departments of Pediatrics at Pochon CHA University, Sungnam, Korea

Youngki Kim

University of Minnesota, Minneapolis, Minnesota, USA

Kee Hyuck Kim

NHIC Ilsan Hospital, Koyang, Korea

Hyeon Joo Jeong

Department of Pathology, Yonsei University College of Medicine, Seoul, Korea

Myung-Hee Shin

Department of Social and Preventive Medicine, Sungkyunkawa University School of Medicine, Suwon, Korea

Silvia Rozen

University of Minnesota, Minneapolis, Minnesota, USA

Michael Mauer

University of Minnesota, Minneapolis, Minnesota, USA, mauer002{at}umn.edu

Introduction. Reduction in renal mass in rats results in progressive proteinuria, hypertension, focal-segmental glomerulosclerosis (FSG), atrophy of tubules (AT), and interstitial expansion. We reported that slow reduction of renal tissue in rats (slow ablation) ending in the removal of 1.5 kidneys is associated, over the next six months, with higher albumin excretion rates (AER) and accelerated development of FSG lesions compared to sudden equivalent renal mass reduction. It was hypothesised that slow reduction of nephron numbers allows for a process of conditioning of residual nephrons that increases their susceptibility to subsequent injury.

Methods. To test this idea we treated MünichWistar rats with the angiotensin receptor blocker (ARB) losartan for six weeks during the gradual staged surgical removal of 1.5 kidneys, and compared them to sham operated controls, and parallel groups untreated by losartan.

Results. Despite discontinuation of losartan over the subsequent six months, ARB pre-treatment completely prevented proteinuria and hypertension in these slow renal ablation rats. ARB pre-treatment also largely prevented the subsequent development of FSG,AT, and interstitial expansion in these animals. Both losartan-treated and untreated renal ablation groups had glomerular enlargement and compensatory hyperfiltration and this was uninfluenced by losartan.

Conclusion. Temporary ARB administration during gradual renal mass reduction resulted in long-term prevention of hypertension and albuminuria and greatly reduced FSG and tubular and interstitial lesions. We hypothesise that the preconditioning of residual nephrons in the gradual ablation model which facilitates their subsequent injury, is blunted by renin-angiotensin system blockade.

Key Words: angiotensin receptor blockade • focal segmental glomerulosclerosis • proteinuria • rats • renal ablation

References

• Brenner BM AMGEN International Prize: The history and future of renoprotection. Kidney Int 2003;64:1163-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kim KH, Kim Y., Park HW, Jeong HJ, Mauer M. A re-evaluation of the renal ablation model of progressive renal disease in rats. J Nephrol 2003;16:196-202.[Web of Science][Medline] [Order article via Infotrieve]
• Zatz R., Dunn BR, Meyer TW, Anderson S., Rennke HG, Brenner BM Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-30.[Web of Science][Medline] [Order article via Infotrieve]
• Mackenzie HS, Troy JL, Rennke HG, Brenner BM TCV 116 prevents progressive renal injury in rats extensive renal mass ablation. J Hypertens 1994;12:S11-S16.
• Weibel ER Stereological methods. In, Weibel ER Ed. Practical Methods for Biological Morphometry. London: Academic Press 1979;44-5.
• Lane PH, Steffes MW, Mauer SM Estimation of glomerular volume: A comparison of four methods. Kidney Int 1992;41:1085-9.[Web of Science][Medline] [Order article via Infotrieve]
• Raij L., Azar S., Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137-43.[Web of Science][Medline] [Order article via Infotrieve]
• Lane PH, Steffes MW, Fioretto P., Mauer SM Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993;43:661-7.[Web of Science][Medline] [Order article via Infotrieve]
• Ibrahim HN, Hostetter TH The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol 1998;9:72-6.[Abstract]
• Lafferty HM, Brenner BM Are glomerular hypertension and `hypertrophy` independent risk factors for progression of renal disease? Sems in Nephrol 1990;10:294-304.
• Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F93.[Web of Science][Medline] [Order article via Infotrieve]
• Nath KA, Kren SM, Hostetter TH Dietary protein restriction in established renal injury in the rat. J Clin Invest 1986;78:1199-205.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Anderson S., Rennke HG, Brenner BM Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.[Web of Science][Medline] [Order article via Infotrieve]
• Fogo A., Ichikawa I. Evidence for the central role of glomerular growth promoters in the development of sclerosis. Sems in Nephrol 1989;9:329-42.
• Dworkin LD, Benstein JA, Tolbert E., Feiner HD Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 1996;7:437-42. 16. Lax DS, Benstein JA, Tolbert E., Dworkin LD Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 1992;41:1527-34.[Web of Science][Medline] [Order article via Infotrieve]
• Yoshida Y., Fogo A., Ichikawa I. Glomerular haemodynamic changes vs. Hypertrophy in experimental glomerular sclerosis. Kidney Int 1989;35:654-60.[Web of Science][Medline] [Order article via Infotrieve]
• Soldner A., Spahn-Langguth H., Mutschler E. HPLC assays to simultaneously determine the angiotensin-AT antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats. J Pharma Biomed Anal 1998;16:863-73.[CrossRef]
• Bergstrom G., Johansson I., Wickman A., Gan L., Thorup C. Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure. J Hypertens 2002;20:1413-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nagai Y., Yao L., Kobori H. et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005;16:703-11.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 3, 110-117 (2007)
DOI: 10.3317/jrass.2007.022


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hye Won Park Articles by Mauer, M. Search for Related Content PubMed PubMed Citation Articles by Hye Won Park, Articles by Mauer, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Kidney Diseases Hazardous Substances DB LOSARTAN POTASSIUM Social Bookmarking                         What's this?